Category:

The use of polygenic risk scores in clinical practice can exacerbate health disparities in ethnic and minority populations

This blog is a summary of our recent commentary on polygenic risk scores (PRS). PRS provide a rapidly emerging example of precision medicine and are based on multiple gene variants that each have weak associations with disease risks, but collectively may enhance disease predictive value in the population. The added value of PRS is unclear Read More >

Posted on by Megan C Roberts, UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy; Muin J Khoury, Office of Public Health Genomics, Centers for Disease Control and Prevention; George A Mensah, Center for Translation Research and Implementation Science, National Institutes of Health, National Heart, Lung, and Blood Institute1 CommentTags , , ,

Can Big Data Science Deliver Precision Public Health?

a big data word globe held by a person and a crowd of people with a small group being focused on

This blog is a quick summary of our recent paper in Public Health Genomics.   Increasingly, a large volume of health and non-health related data from multiple sources is becoming available that has the potential to drive health related discoveries and implementation. The term “big data” is often used as a buzzword to refer to large Read More >

Posted on by Muin J. Khoury, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia; Michael Engelgau, George A. Mensah, Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, Bethesda, Maryland; David A. Chambers, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MarylandLeave a commentTags

Introducing the CDC Tier-Classified Guidelines Database

a database image with Tier 1 in green, Tier 2 in yellow and Tier 3 in red

Over the last several years, OPHG has hosted a “Tier Table” database of genomic applications (i.e., clinical scenarios involving genomic testing) sorted into one of three tiers using a method described in Clinical Pharmacology and Therapeutics, 2014. The purpose of creating the database was to help organize evidence (such as recommendation statements contained in guidelines, Read More >

Posted on by W. David Dotson, Wei Yu, and Muin J. Khoury, Office of Public Health Genomics, Centers for Disease Control and PreventionLeave a commentTags ,

Frequently Asked Questions about the CDC Tier-Classified Guidelines Database

Over the last several years, OPHG has hosted a “Tier Table” database of genomic applications (i.e., clinical scenarios involving genomic testing) sorted into one of three tiers using a method described in Clinical Pharmacology and Therapeutics, 2014. The Tier Table is being replaced with our new Tier-Classified Guidelines Database, which we hope will promote more Read More >

Posted on by W. David Dotson, Wei Yu, and Muin J. Khoury, Office of Public Health Genomics, Centers for Disease Control and PreventionLeave a commentTags , ,